The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use{star, open}

Research in Social and Administrative Pharmacy

Volumn 1, Issue 2, 2005, Pages 139-157

  Hansen, Richard A ^a   Schommer, Jon C ^b   Cline, Richard R ^b   Hadsall, Ronald S ^b   Schondelmeyer, Stephen W ^b   Nyman, John A ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Claims data; Cost sharing; Direct to consumer advertising; Insurance; Utilization

Indexed keywords

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIULCER AGENT; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP;

ADOLESCENT; ADULT; ADVERTIZING; ARTICLE; COST; COST CONTROL; DRUG ANTAGONISM; DRUG UTILIZATION; ECONOMICS; FEMALE; HEALTH INSURANCE; HUMAN; MALE; MIDDLE AGED; PRESCRIPTION; STATISTICS;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; ADVERTISING; ADVERTISING AS TOPIC; ANTI-ULCER AGENTS; COST CONTROL; COST SHARING; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HEALTH BENEFIT PLANS, EMPLOYEE; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MIDDLE AGED; OMEPRAZOLE; PRESCRIPTIONS, DRUG; PROTON PUMPS;

EID: 27744574052     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2005.03.002     Document Type: Article

References (39)

1. Blumenthal D. Controlling health care expenditures. N Engl J Med 344 (2001) 766-769
2. Oberlander J. The U.S. health care system: on a road to nowhere?. Can Med Assoc J 167 (2002) 163-168
3. Levit K.S., Cowan C., Lazenby C., et al. Trends in U.S. health care spending, 2001. Health Aff 22 (2003) 154-155
4. CMS. The CMS Chart Series (2001), Center for Medicare and Medicaid Services, Washington, DC
5. NIHCM. Prescription Drug Expenditures in 2001: Another Year of Escalating Costs (2002), National Institute for Health Care Management; Research and Educational Foundation, Washington, DC
6. Dubois R.W., Chawla A.J., Neslusan C.A., Smith M.W., and Wade S. Explaining drug spending trends. Health Aff 19 (2000) 231-239
7. NIHCM. Prescription Drugs and Mass Media Advertising, 2000 (2001), National Institute for Health Care Management, Washington, DC
8. Leibowitz A., Manning W.G., and Newhouse J.P. The demand for prescription drugs as a function of cost-sharing. Soc Sci Med 21 (1985) 1063-1069
9. Manning W.G., Newhouse J.P., Duan N., et al. Health insurance and the demand for medical care: a randomized experiment. Am Econ Rev 77 (1987) 251-277
10. Schommer J.C., Doucette, William R., Mehta, and Bella H. Rote learning after exposure to a direct-to-consumer television advertisement for a prescription drug. Clin Ther 20 (1998) 617-632
11. Findlay S.D. Direct-to-consumer promotion of prescription drugs: economic implications for patients, payers and providers. Pharmacoeconomics 19 (2001) 109-119
12. Wilkes M., Bell R.A., and Kravitz R.L. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff 19 (2000) 110-128
13. Weissman J.S., Blumenthal D., Silk A.J., et al. Physicians report on patient encounters involving direct-to-consumer advertising. Health Aff (Millwood) (2004)
14. Murray E., Lo B., Pollack L., Donelan K., and Lee K. Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship. J Am Board Fam Pract 17 (2004) 6-18
15. Business and Health Institute. Rx Coverage and Consumer Ads: A Costly Combo (1998), Business and Health Institute; DataWatch, Montvale, NJ
16. Merlis M. Explaining the Growth in Prescription Drug Spending: A Review of Recent Studies (2000), Institute for Health Policy Solutions, Washington, DC
17. Coulson N.E., Terza J.V., Neslusan C.A., and Stuart B. Estimating the moral-hazard effect of supplemental medical insurance in the demand for prescription drugs by the elderly. Am Econ Rev 85 (1995) 122-126
18. Artz M.B., Hadsall R.S., and Schondelmeyer S.W. Impact of generosity level of outpatient prescription drug coverage on prescription drug events and expenditure among older persons. Am J Public Health 92 (2002) 1257-1263
19. Zachary W.M., Shepherd M.D., Hinch M., et al. Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. Am J Health Syst Pharm 59 (2002) 42-49
20. Vogel R.J., Ramachandran S., and Zachry W.M. A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals. Clin Ther 25 (2003) 309-329
21. De Sloover Koch Y., Ernst M.E., and Kelly M.W. Patient perceptions about drug advertising and prescription-to-nonprescription switches. Am J Health Syst Pharm 59 (2002) 1568
22. Liang S.Y., Phillips K.A., Tye S., Haas J.S., and Sakowski J. Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services. Am J Manag Care 10 (2004) 99-107
23. Balkrishnan R., Byerly W.G., Camacho F.T., Shrestha A., and Anderson R.T. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population. Am J Manag Care 7 (2001) 1093-1100
24. Ganther-Urmie J.M., Nair K.V., Valuck R., McCollum M., Lewis S.J., and Turpin R.S. Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans. Am J Manag Care 10 (2004) 201-208
25. Aikin K.J., and Swasy J.L. Direct-to-consumer advertising of prescription drugs: impact of asking for information about treatment cost. Available at: (2002). http://www.fda.gov/cder/ddmac/Presentations/KitFDLI2002aout/index Accessed October 3, 2003
26. Andersen R., and Newman J. Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc 51 (1973) 95-124
27. Andersen R., and Aday L. Access to medical care in the U.S.: realized and potential. Med Care 16 (1978) 533-546
28. Aday L.R., and Andersen R. A framework for the study of access to medical care. Health Serv Res 9 (1974) 208-220
29. Cardinale V. Drug Topics Redbook (1999), Medical Economics Co, Montvale, NJ
30. MEDSTAT Group. MEDSTAT MarketScan Users Manual (2001), Thompson Company, Ann Harbor, Mich
31. Nielsen Media Research, Inc. Nielsen media research 1998 report on television (1998), Nielsen Media Research, Inc, New York
32. Nielsen Media Research, Inc. Nielsen media research local universe estimates. Available at: (2003). http://www.nielsenmedia.com Accessed October 3, 2003
33. Smith M. Pharmaceutical Marketing; Strategies and Cases (1991), Pharmaceutical Products Press, Binghamton
34. U.S. Census Bureau. 1997 Economic Census Maps. Available at:. http://www.census.gov/prod/www/abs/97ecmaps Accessed October 3, 2003
35. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992) 613-619
36. STATA. STATA Release 8 (2003), STATA Corporation, College Station, Tex
37. Robinson A.R., Hohmann K.B., Rifkin J.I., et al. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Arch Intern Med 164 (2004) 427-432
38. Remler D.K., and Atherly A.J. Health status and heterogeneity of cost-sharing responsiveness: how do sick people respond to cost-sharing?. Health Econ 12 (2003) 269-280
39. Hillman A.L., Pauly M.V., Escarce J.J., et al. Financial incentives and drug spending. Health Aff 18 (1999) 189-200